{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T22:57:23Z","timestamp":1776466643612,"version":"3.51.2"},"reference-count":13,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T00:00:00Z","timestamp":1719964800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jinf.2024.106221","type":"journal-article","created":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T17:58:54Z","timestamp":1720634334000},"page":"106221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The impact of COVID-19 vaccine spring boosters on COVID-19 hospital admissions in England 2022\/23"],"prefix":"10.1016","volume":"89","author":[{"given":"Nick","family":"Andrews","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1037-9346","authenticated-orcid":false,"given":"Itunu","family":"Osuntoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Stowe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Freja C.M.","family":"Kirsebom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6998-447X","authenticated-orcid":false,"given":"Alex","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie","family":"Lopez Bernal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2024.106221_bib1","unstructured":"Joint Committee on Vaccination and Immunisation (JCVI) statement on COVID-19 vaccinations in 2022: 21 February 2022. Available at: \u3008https:\/\/www.gov.uk\/government\/publications\/joint-committee-on-vaccination-and-immunisation-statement-on-covid-19-vaccinations-in-2022\/joint-committee-on-vaccination-and-immunisation-jcvi-statement-on-covid-19-vaccinations-in-2022-21-february-2022\u3009 [Accessed 20th June 2024]."},{"key":"10.1016\/j.jinf.2024.106221_bib2","unstructured":"JCVI statement on spring 2023 COVID-19 vaccinations, 22 February 2023. Available at: \u3008https:\/\/www.gov.uk\/government\/publications\/spring-2023-covid-19-vaccination-programme-jcvi-advice-22-february-2023\/jcvi-statement-on-spring-2023-covid-19-vaccinations-22-february-2023\u3009 [Accessed 20th June 2024]."},{"key":"10.1016\/j.jinf.2024.106221_bib3","unstructured":"Weekly national Influenza and COVID-19 surveillance report Week 36 report. Available at: \u3008https:\/\/assets.publishing.service.gov.uk\/media\/6319c191d3bf7f77cfa8dd35\/Weekly_Flu_and_COVID-19_report_w36.pdf\u3009 [Accessed 20th June 2024]."},{"key":"10.1016\/j.jinf.2024.106221_bib4","unstructured":"National Influenza and COVID-19 surveillance report Week 27 report. Available at \u3008https:\/\/assets.publishing.service.gov.uk\/media\/64a694f24dd8b3000c7fa57b\/Weekly_Flu_and_COVID-19_report_w27.pdf\u3009 [Accessed 20th June 2024]."},{"issue":"10","key":"10.1016\/j.jinf.2024.106221_bib5","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/cid\/ciy906","article-title":"The use of quasi-experimental designs for vaccine evaluation","volume":"68","author":"Lopez Bernal","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2024.106221_bib6","article-title":"Regression discontinuity design studies: a guide for health researchers","volume":"384","author":"Calonico","year":"2024","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.jinf.2024.106221_bib7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/aje\/kwac157","article-title":"Estimating the effectiveness of first dose of COVID-19 vaccine against mortality in England: a quasi-experimental study","volume":"192","author":"Bermingham","year":"2023","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jinf.2024.106221_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2021.100134","article-title":"Reduced COVID-19 hospitalizations among New York City residents following age-based SARS-CoV-2 vaccine eligibility: evidence from a regression discontinuity design","volume":"10","author":"Greene","year":"2022","journal-title":"Vaccine X"},{"key":"10.1016\/j.jinf.2024.106221_bib9","unstructured":"UKHSA COVID-19 vaccine surveillance report: Week 40. Available at: \u3008https:\/\/assets.publishing.service.gov.uk\/media\/6363ade0d3bf7f04e12196f8\/vaccine-surveillance-report-week-40.pdf\u3009 [Accessed 20th June 2024]."},{"issue":"11","key":"10.1016\/j.jinf.2024.106221_bib10","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S1473-3099(23)00365-1","article-title":"Duration of protection of ancestral-strain monovalent vaccines and effectiveness of bivalent BA.1 boosters against COVID-19 hospitalisation in England: a test-negative case-control study","volume":"23","author":"Kirsebom","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jinf.2024.106221_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102587","article-title":"Effectiveness of the Sanofi\/GSK (VidPrevtyn Beta) and Pfizer-BioNTech (Comirnaty Original\/Omicron BA.4-5) bivalent vaccines against hospitalisation in England","volume":"71","author":"Kirsebom","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jinf.2024.106221_bib12","unstructured":"Secondary Uses Service (SUS) \u2013 NHS Digital. Available at: \u3008https:\/\/digital.nhs.uk\/services\/secondary-uses-service-sus\u3009 [Accessed 20th June 2024]."},{"key":"10.1016\/j.jinf.2024.106221_bib13","article-title":"Effect of second booster vaccinations and prior infection against SARS-CoV-2 in the UK SIREN healthcare worker cohort","volume":"36","author":"Kirwan","year":"2023","journal-title":"Lancet Reg Health Eur"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445324001555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445324001555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T02:34:45Z","timestamp":1728009285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445324001555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0163445324001555"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2024.106221","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of COVID-19 vaccine spring boosters on COVID-19 hospital admissions in England 2022\/23","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2024.106221","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2024 Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}],"article-number":"106221"}}